Deepnoid at Medical Device Exhibition 'Arab Health 2024'... Exploring Business Opportunities in Middle East Market

Leading Domestic Medical AI Company Showcases Technology
Disease Diagnosis Support Solution DEEP:AI Exhibited
Arab Health, Over 3,500 Companies Worldwide Participate

Deepnoid, a first-generation domestic medical artificial intelligence (AI) development company, announced on the 23rd that it will participate in the international medical device exhibition "Arab Health 2024," held at the Dubai World Trade Center in the United Arab Emirates (UAE) from the 29th of this month to the 1st of next month.

Deepnoid will showcase its AI-based 3D medical imaging analysis solutions DEEP:NEURO, DEEP:LUNG, and the 2D medical imaging analysis solution DEEP:CHEST at the exhibition.

The Middle East holds high growth potential as a medical device market. The Korea Institute for International Economic Policy forecasted that the UAE medical device market size will grow to $1.3376 billion (approximately 1.789 trillion KRW) by 2026.

Choi Woosik, CEO of Deepnoid, stated, "This year, we plan to expand our business scope not only domestically but also into overseas AI markets," adding, "We are targeting the Middle East as the next market following Southeast Asia." He further said, "We intend to use the Middle East and other multinational companies as a foothold to increase overseas sales."

"Arab Health" is the largest medical device exhibition in the Middle East, marking its 49th edition this year. The exhibition features participation and exhibits from over 3,450 companies from 180 countries. Exhibition halls for 70 countries are also prepared, with global medical device companies participating as well.

This content was produced with the assistance of AI translation services.